了解共同设计的放疗前锻炼计划的可行性——一项单臂研究 (PReFACe)
社协同设计的放疗前运动计划对于I-III期非小细胞肺癌患者实施可行性的单中心单臂先导研究
本临床试验旨在了解为I-III期非小细胞肺癌患者设计的放疗前联合锻炼方案的可行性。该方案涉及肺癌患者在放射治疗科内,于每次治疗前立即进行20分钟的个性化强度锻炼。
主要研究问题包括:
通过监测招募率、锻炼课程出勤率及规定锻炼强度的依从性,了解该锻炼方案的可接受性。同时监测不良事件以评估方案安全性。
将对参与者、其家属及医疗保健专业人员进行后续定性访谈,以进一步探讨锻炼方案的可接受性。
总计,参与者将被邀请进行二十次、在放射治疗科内每次治疗前立即进行的监督锻炼课程。每次锻炼课程持续二十分钟,并使用固定式健身自行车进行。关于锻炼强度,根据参与者的锻炼史、基础锻炼经验和个人偏好,可能有四个级别可供选择。在整个方案中,参与者可根据依从性和偏好在锻炼强度级别上进级或降级。
研究概览
详细说明
这是一项序贯、混合方法的可行性研究,包括两个阶段:
第一阶段:定量数据收集(可行性结果)
第二阶段:定性数据收集(半结构化访谈)
本研究使用的运动计划是通过一系列涉及肺癌患者和医疗保健专业人员的研讨会和会议共同设计的。
符合条件的参与者必须接受处方放疗剂量55 Gy,分为二十次,每日一次,每周五次,共四周。据此,参与者将获得总共二十次运动训练,每日一次,并与放疗治疗时间安排相对应。
运动强度因人而异,基于参与者在基线评估时进行的亚极量运动测试。该测试将用于确定每位参与者的最大心率,然后用Karvonen公式(Karvonen等,1957)计算储备心率百分比。该计算将建立对应于轻、中、高运动强度的个体心率范围。起始运动强度级别(1-4)将根据基线六分钟步行测试、临床虚弱评分和参与者偏好来确定。
四个级别的运动强度难度递增,并包含不同持续时间的中、中或高强度运动,包括:
- 第一级:10分钟轻度持续热身→10分钟中度持续力量训练
- 第二级:5分钟轻度持续热身→15分钟中度持续力量训练
- 第三级:5分钟轻度持续热身→10分钟中度持续力量训练→5分钟(30秒)高强度间歇
- 第四级:5分钟轻度持续热身→5分钟(30秒)高强度间歇→5分钟中度持续力量训练→5分钟(30秒)高强度间歇
所有参与者在每次运动训练中将佩戴胸带心率监测器,以确保他们以规定的强度进行锻炼。依从性定义为完成至少75%的规定运动持续时间(即15分钟)。
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Matthew Peter Beggs, MSc, BSc
- 电话号码:+44 7759264875.
- 邮箱:mbeggs06@qub.ac.uk
研究联系人备份
- 姓名:Gillian Dr Prue, PhD., HCPC, FHEA, MCSP
- 电话号码:+44 28 9097 2345
- 邮箱:g.prue@qub.ac.uk
学习地点
-
-
Antrim
-
Belfast、Antrim、英国、BT9 7JL
- 招聘中
- Northern Ireland Cancer Centre, City Hospital, BHSCT
-
接触:
- Matthew Peter Beggs, MSc, BSc
- 电话号码:+44 7759264875
- 邮箱:mbeggs06@qub.ac.uk
-
首席研究员:
- Cathryn Dr Crockett, Consultant Clinical Oncologist
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
纳入标准:
- 经临床或组织学确诊为非小细胞肺癌1-3期的患者。
- 计划接受以根治性放疗为主要治疗方式。
- ECOG体能状态评分0-2级。
- 年满18周岁。
- 能够理解并用英语进行交流。
- 通过主治医师填写医疗许可表,被认为适合参加中等强度运动以及心电图监测的最大运动测试。
- 能够提供书面知情同意书。
排除标准:
- 不稳定或新发心绞痛(过去一个月内确诊)。
- 过去3个月内发生不稳定或急性心力衰竭、心肌病或其他未控制的心脏病(以症状性液体潴留、过度呼吸困难、体重快速增加、脚踝肿胀或凹陷性水肿为证据)。
- 出现新发或未控制的心律失常。
- 已确诊或疑似脊髓压迫。
- 未控制的糖尿病(例如:一个月内调整药物、过去两周内出现低血糖发作,或过去两周内运动后高血糖不降低)。
- 正在接受化疗或免疫治疗的联合治疗。
- 当前存在活动性第二恶性肿瘤,非黑色素瘤皮肤癌除外。
- 过去3个月内对承重骨进行过骨科手术。
- 运动或体力活动时出现胸痛。
- 无 > 2级周围神经病变。
- 超出局限性转移的转移性疾病(例如骨或脑)。
- 心电图监测的最大运动测试中发现任何异常,需提前终止或禁止体力活动。
- 身体残疾,限制其在本研究使用的固定式健身自行车上安全运动能力的人。
- 非英语使用者。
孕妇。
- 参与其他临床研究的患者 - 作为额外考虑,如果患者目前正在参加另一项运动或体力活动研究,将被排除,因为这可能影响两项研究的结果。然而,如果他们在本研究前参与过研究或目前参与不相关领域的研究,我们不会立即将其排除,而是由博士生、首席研究员和主要研究员讨论其参与,以确定安全且合适的入组方案。
- 身体残疾 - 遗憾的是,我们提供替代运动以适应身体残疾者的能力有限。具体来说,BCH主健身房愿意支持本研究,向研究团队出借固定式健身自行车。然而,由于医疗机构内设备可用性的限制以及有限的资金/资源购买设备,身体残疾限制其安全地在固定自行车上运动的人将被排除在本研究之外。理想情况下,我们也会提供卧式固定自行车以支持更多身体残疾者参与本研究。
学习计划
研究是如何设计的?
设计细节
- 主要用途:其他
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Pre-Radiotherapy exercise arm
Participants within the experimental arm will participate in the co-designed, pre-radiotherapy exercise programme alongside treatment.
|
Participants will participate in up to twenty, supervised exercise sessions, performed within the radiotherapy department, immediately before each treatment.
Each session has a 20 minute duration at one of four exercise intensity levels based on the participants baseline assessment results, and preferences.
Study participants will have been diagnosed with stage I-III NSCLC and prescribed radiotherapy administered as 55Gy in 20 fractions over 4 weeks or 60Gy in 15 fractions over 3 weeks as their primary treatment as per standard treatment pathways within the trust
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
合格率
大体时间:筛选与入组
|
通过参与者筛选识别并接触的合格参与者百分比
|
筛选与入组
|
|
运动项目出勤率
大体时间:第4-8周(PReFACe锻炼计划)
|
总出席次数占提供总次数的比例
|
第4-8周(PReFACe锻炼计划)
|
|
Adherence to the exercise programme
大体时间:第4~8周(PReFACe锻炼计划)
|
监测参与者在每次训练中完成建议时长和强度的锻炼能力(若能完成75%的时长且未修改强度,则视为依从)
|
第4~8周(PReFACe锻炼计划)
|
|
Recruitment rate
大体时间:Screening and recruitment
|
The total number of potential participants who were approached and agreed to participate as a percentage of the total number who were approached
|
Screening and recruitment
|
|
Participant retention rates
大体时间:Week 0 (baseline assessment) to week 8 (PReFACe exercise programme end and post-intervention assessment)
|
The number of participants available to provide outcomes at the post-intervention assessment as a percentage of the total number recruited.
|
Week 0 (baseline assessment) to week 8 (PReFACe exercise programme end and post-intervention assessment)
|
|
Adverse event Common Terminology Criteria for Adverse Events (CTCAE) v5
大体时间:Week 0 (baseline assessment) to week 8 (PReFACe exercise programme end and post-intervention assessment)
|
Assess the tolerability and safety of the intervention, via recording of intervention-associated adverse events (AE). AEs will be graded according to CTCAE v.5 as:
|
Week 0 (baseline assessment) to week 8 (PReFACe exercise programme end and post-intervention assessment)
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change from baseline in quality of life using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30-items (EORTC QLQ-30)
大体时间:Week 0 (baseline assessment) to week 8 (end of study assessment)
|
EORTC QLQ-30 is a reliable and validated, multidimensional quality-of-life questionnaire which is widely used in research for people with lung cancer. The QLQ-C30 is composed of both multi-item scales and single-item measures, including: Five functional scales:
Three symptoms' scales:
A Global health Status (QoL) Six single items:
All scales and single-item measures range in score from 0 to 100. High scale scores represent a higher response level, thus:
|
Week 0 (baseline assessment) to week 8 (end of study assessment)
|
|
Change from baseline in quality of life using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Lung Cancer 13 (EORTC QLQ-LC13)
大体时间:Week 0 (baseline assessment) to week 8 (end of study assessment)
|
EORTC QLQ-LC13 is a reliable and validated, multidimensional quality-of-life questionnaire which is widely used in research for people with lung cancer. The QLQ-LC13 incorporates one multi-item scale to assess dyspnoea, and a series of single items assessing:
All single-item measures range in score from 0 to 100 with high scale scores representing a higher response level, thus: - High symptom scale/ single item scores = higher symptom burden |
Week 0 (baseline assessment) to week 8 (end of study assessment)
|
|
Impact of exercise programmes effect on symptom burden: Pain likert Scale
大体时间:Week 0 (baseline assessment) to week 8 (end of study assessment)
|
Understanding the impact of the exercise programme on symptom burden on participants experience of pain using a 1-10 likert scale:
|
Week 0 (baseline assessment) to week 8 (end of study assessment)
|
|
Impact of exercise programmes effect on symptom burden: Fatigue likert Scale
大体时间:Week 0 (baseline assessment) to week 8 (end of study assessment)
|
Understanding the impact of the exercise programme on symptom burden on participants experience of fatigue using a 1-10 likert scale:
|
Week 0 (baseline assessment) to week 8 (end of study assessment)
|
|
Impact of exercise programmes effect on symptom burden: Modified Medical Research Council (MRC) dyspnoea scale
大体时间:Week 0 (baseline assessment), daily through PReFACe exercise programme (weeks 4-8) and end of study assessment (week 8)
|
The modified MRC dyspnoea scale is a 5-point (0-4) questionnaire that assesses a patient's breathing difficulty, or dyspnoea, during activity. Higher scores correspond with more breathlessness etc:
|
Week 0 (baseline assessment), daily through PReFACe exercise programme (weeks 4-8) and end of study assessment (week 8)
|
|
To assess the accessibility, acceptability and experience of the exercise programme through semi-structured qualitative interviews
大体时间:Weeks 8-14 post-intervention follow-up period
|
Conduct of post-intervention, semi-structured, qualitative interviews with the following groups:
A total of 15 participants (n=5 from each group) is deemed sufficient to achieve data saturation. Semi-structured interview schedules were pre-constructed for each group. Interview schedules consist of open-ended questions to explore the participants/experience of the exercise programme in their own words. No scales are used as a part of this outcome. |
Weeks 8-14 post-intervention follow-up period
|
|
Baseline compared to post-intervention changes in participant distress levels using the National Comprehensive Cancer Network (NCCN) Distress thermometer.
大体时间:Baseline assessment (week 0), weekly throughout the PReFACe exercise programme (weeks 4-8) and at post-study assessment (week 8)
|
The distress thermometer is a valid, and accurate screening tool used to quickly monitor for patient's distress with advanced cancer. The thermometer uses a 0-10 scale to measure patient distress over the past week with 0 representing no distress and 10 representing extreme distress. The thermometer also features a "Problem List" (covering practical, family, emotional, spiritual, and physical issues) to pinpoint causes of distress for referral |
Baseline assessment (week 0), weekly throughout the PReFACe exercise programme (weeks 4-8) and at post-study assessment (week 8)
|
|
Change in baseline to post-intervention physical fitness: Six- minute walking test
大体时间:Baseline assessment (week 0) and post-study assessment (week 8)
|
A well-documented, validated and standardised sub-maximal fitness test measuring the distance a person can walk on a flat, solid surface in six minutes. Participants walk back and forth along a measured track to measure total distance covered in meters within six minutes. Greater distance covered (meters) indicate greater baseline fitness. Greater post-test distance covered (meters) than baseline scores indicate improvements in basic mobility. Reduced post-test distance covered (meters) than baseline scores indicate reductions in basic mobility. |
Baseline assessment (week 0) and post-study assessment (week 8)
|
|
Change in baseline to post-intervention physical fitness: 30-second sit-to-stand
大体时间:Baseline assessment (week 0) and post-study assessment (week 8)
|
A well-documented, validated, and standardised test to measure functional lower extremity strength.
Participants perform as many sit-to-stand reps as they can within 30 seconds.
|
Baseline assessment (week 0) and post-study assessment (week 8)
|
|
Change in baseline to post-intervention physical functioning: Rockwood Clinical Frailty Scale (CFS)
大体时间:Baseline assessment (week 0) and post-study assessment (week 8)
|
The Rockwood CFS is used as a valid assessment tool for screening frailty in older adults. This is a 1-9 scale, with higher scores indicating greater frailty:
|
Baseline assessment (week 0) and post-study assessment (week 8)
|
|
Change in baseline to post-intervention physical activity: The International Physical Activity Questionnaire - Short Form (IPAQ-SF)
大体时间:Baseline assessment (week 0) and post-study assessment (week 8)
|
The IPAQ-SF will be used to explore the influence of the pre-radiotherapy exercise programme on the participant's weekly physical activity levels pre- and post-study. Based on results, physical activity levels based on scores can be calculated as:
|
Baseline assessment (week 0) and post-study assessment (week 8)
|
|
Change in baseline to post-intervention physical activity: Huffman Exercise Satisfactions Scale
大体时间:Baseline assessment (week 0) and post-study assessment (week 8)
|
The Huffman Exercise Satisfaction Scale was developed with stakeholders as a novel approach to measure older adults (aged ≥55 years) satisfaction with their physical activity levels. There questionnaire measures two scales:
Mean scores are taken from each scale to total participants exercise enjoyment and satisfaction. |
Baseline assessment (week 0) and post-study assessment (week 8)
|
合作者和调查者
出版物和有用的链接
一般刊物
- Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011 Apr 23;6:42. doi: 10.1186/1748-5908-6-42.
- Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005 Aug 30;173(5):489-95. doi: 10.1503/cmaj.050051.
- Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, Boyd KA, Craig N, French DP, McIntosh E, Petticrew M, Rycroft-Malone J, White M, Moore L. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021 Sep 30;374:n2061. doi: 10.1136/bmj.n2061.
- Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer. 1994;30A(5):635-42. doi: 10.1016/0959-8049(94)90535-5.
- Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 Mar 3;85(5):365-76. doi: 10.1093/jnci/85.5.365.
- Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): a systematic review. Int J Behav Nutr Phys Act. 2011 Oct 21;8:115. doi: 10.1186/1479-5868-8-115.
- KARVONEN MJ, KENTALA E, MUSTALA O. The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn. 1957;35(3):307-15. No abstract available.
- Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer. 1995 Jun;12(3):199-220. doi: 10.1016/0169-5002(95)00450-f.
- Peddle-McIntyre CJ, Singh F, Thomas R, Newton RU, Galvao DA, Cavalheri V. Exercise training for advanced lung cancer. Cochrane Database Syst Rev. 2019 Feb 11;2(2):CD012685. doi: 10.1002/14651858.CD012685.pub2.
- Sasso JP, Eves ND, Christensen JF, Koelwyn GJ, Scott J, Jones LW. A framework for prescription in exercise-oncology research. J Cachexia Sarcopenia Muscle. 2015 Jun;6(2):115-24. doi: 10.1002/jcsm.12042. Epub 2015 May 11.
- Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, Zucker DS, Matthews CE, Ligibel JA, Gerber LH, Morris GS, Patel AV, Hue TF, Perna FM, Schmitz KH. Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390. doi: 10.1249/MSS.0000000000002116.
- Cormie P, Zopf EM, Zhang X, Schmitz KH. The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects. Epidemiol Rev. 2017 Jan 1;39(1):71-92. doi: 10.1093/epirev/mxx007.
- Pearson N, Naylor PJ, Ashe MC, Fernandez M, Yoong SL, Wolfenden L. Guidance for conducting feasibility and pilot studies for implementation trials. Pilot Feasibility Stud. 2020 Oct 31;6(1):167. doi: 10.1186/s40814-020-00634-w.
- Avancini A, Sartori G, Gkountakos A, Casali M, Trestini I, Tregnago D, Bria E, Jones LW, Milella M, Lanza M, Pilotto S. Physical Activity and Exercise in Lung Cancer Care: Will Promises Be Fulfilled? Oncologist. 2020 Mar;25(3):e555-e569. doi: 10.1634/theoncologist.2019-0463. Epub 2019 Nov 26.
- Totton N, Lin J, Julious S, Chowdhury M, Brand A. A review of sample sizes for UK pilot and feasibility studies on the ISRCTN registry from 2013 to 2020. Pilot Feasibility Stud. 2023 Nov 21;9(1):188. doi: 10.1186/s40814-023-01416-w.
- Church S, Rogers E, Rockwood K, Theou O. A scoping review of the Clinical Frailty Scale. BMC Geriatr. 2020 Oct 7;20(1):393. doi: 10.1186/s12877-020-01801-7.
- Viamonte SG, Joaquim AV, Alves AJ, Vilela E, Capela A, Ferreira C, Duarte BF, Rato ND, Teixeira MP, Tavares A, Santos M, Ribeiro F. Cardio-Oncology Rehabilitation for Cancer Survivors With High Cardiovascular Risk: A Randomized Clinical Trial. JAMA Cardiol. 2023 Dec 1;8(12):1119-1128. doi: 10.1001/jamacardio.2023.3558.
- Ziolkowska-Suchanek I. Mimicking Tumor Hypoxia in Non-Small Cell Lung Cancer Employing Three-Dimensional In Vitro Models. Cells. 2021 Jan 12;10(1):141. doi: 10.3390/cells10010141.
- Seet-Lee C, Yee J, Morahan H, Ross LS, Edwards KM. The effect of aerobic exercise on tumour blood delivery: a systematic review and meta-analysis. Support Care Cancer. 2022 Nov;30(11):8637-8653. doi: 10.1007/s00520-022-07132-0. Epub 2022 Jun 2.
- World Health Organization (2023) Lung Cancer
- World Health Organization (2018) More active people for a healthier world
- Williams, N. (2017) 'The Borg Rating of Perceived Exertion (RPE) scale ', Occupational Medicine, 67 (5), pp. 404-405.
- United Kingdom Lung Cancer Coalition (2024) Driving Quality Improvements in UK Lung Cancer: Utilising good practice and innovation to deliver optimal care and outcomes
- Tran DL, Kamaladasa Y, Munoz PA, Kotchetkova I, D'Souza M, Celermajer DS, Maiorana A, Cordina R. Estimating exercise intensity using heart rate in adolescents and adults with congenital heart disease: Are established methods valid? Int J Cardiol Congenit Heart Dis. 2022 Mar 26;8:100362. doi: 10.1016/j.ijcchd.2022.100362. eCollection 2022 Jun.
- Toohey K, Mizrahi D, Hart NH, Singh B, Lopez P, Hunter M, Newton RU, Schmitz KH, Adams D, Edbrooke L, Hayes S. Exercise in cancer care for people with lung cancer: A narrative synthesis. J Sci Med Sport. 2025 Jan;28(1):16-25. doi: 10.1016/j.jsams.2024.08.002. Epub 2024 Aug 8.
- Tivey A, Ullah M, Beech A, Ng C, Cove-Smith L. Can frailty screening tools predict completion of chemotherapy and chemotherapy toxicity in patients with thoracic malignancy? J Geriatr Oncol. 2020 Sep;11(7):1154-1156. doi: 10.1016/j.jgo.2020.03.002. Epub 2020 Mar 11. No abstract available.
- Suveg K, Plasswilm L, Iseli T, Leskow P, Fischer GF, Putora PM. Role of Adjuvant Radiotherapy in Non-Small Cell Lung Cancer-A Review. Cancers (Basel). 2022 Mar 23;14(7):1617. doi: 10.3390/cancers14071617.
- Sia J, Szmyd R, Hau E, Gee HE. Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer. Front Cell Dev Biol. 2020 Feb 13;8:41. doi: 10.3389/fcell.2020.00041. eCollection 2020.
- Riba MB, Donovan KA, Ahmed K, Andersen B, Braun I, Breitbart WS, Brewer BW, Corbett C, Fann J, Fleishman S, Garcia S, Greenberg DB, Handzo GF, Hoofring LH, Huang CH, Hutchinson S, Johns S, Keller J, Kumar P, Lahijani S, Martin S, Niazi SK, Pailler M, Parnes F, Rao V, Salman J, Scher E, Schuster J, Teply M, Usher A, Valentine AD, Vanderlan J, Lyons MS, McMillian NR, Darlow SD. NCCN Guidelines(R) Insights: Distress Management, Version 2.2023. J Natl Compr Canc Netw. 2023 May;21(5):450-457. doi: 10.6004/jnccn.2023.0026.
- Piraux E, Caty G, Aboubakar Nana F, Reychler G. Effects of exercise therapy in cancer patients undergoing radiotherapy treatment: a narrative review. SAGE Open Med. 2020 Jun 17;8:2050312120922657. doi: 10.1177/2050312120922657. eCollection 2020.
- Pinto BM, Ciccolo JT. Physical activity motivation and cancer survivorship. Recent Results Cancer Res. 2011;186:367-87. doi: 10.1007/978-3-642-04231-7_16.
- Penko AL, Barkley JE, Koop MM, Alberts JL. Borg scale is valid for ratings of perceived exertion for individuals with Parkinson's disease. Int J Exerc Sci. 2017 Jan 1;10(1):76-86. doi: 10.70252/RVAQ3828. eCollection 2017.
- Ortmann BM. Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity. BMJ Oncol. 2024 Feb 1;3(1):e000154. doi: 10.1136/bmjonc-2023-000154. eCollection 2024.
- Norton K, Norton L, Sadgrove D. Position statement on physical activity and exercise intensity terminology. J Sci Med Sport. 2010 Sep;13(5):496-502. doi: 10.1016/j.jsams.2009.09.008. Epub 2009 Dec 10.
- Nisar H, Sanchidrian Gonzalez PM, Brauny M, Labonte FM, Schmitz C, Roggan MD, Konda B, Hellweg CE. Hypoxia Changes Energy Metabolism and Growth Rate in Non-Small Cell Lung Cancer Cells. Cancers (Basel). 2023 Apr 26;15(9):2472. doi: 10.3390/cancers15092472.
- Nikitara K, Odani S, Demenagas N, Rachiotis G, Symvoulakis E, Vardavas C. Prevalence and correlates of physical inactivity in adults across 28 European countries. Eur J Public Health. 2021 Oct 11;31(4):840-845. doi: 10.1093/eurpub/ckab067.
- National Institute of Health, (2021). Common Terminology Criteria for Adverse Events (CTCAE)
- National Institute for Health and Care Excellence (2014) Behaviour Change: Individual Approaches
- National Data Guardian (2020) The Eight Caldicott Principles.
- Muz B, de la Puente P, Azab F, Azab AK. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl). 2015 Dec 11;3:83-92. doi: 10.2147/HP.S93413. eCollection 2015.
- Morgan B, Hejdenberg J, Kuleszewicz K, Armstrong D, Ziebland S. Are some feasibility studies more feasible than others? A review of the outcomes of feasibility studies on the ISRCTN registry. Pilot Feasibility Stud. 2021 Nov 8;7(1):195. doi: 10.1186/s40814-021-00931-y.
- Moreton, R., Stutz, A., Robinson, S., Mulla, I., Winter, M., Roberts, J. & Hillsdon, M. (2018) Evaluation of the Macmillan Physical Activity Behaviour Change Care Pathway
- Moreno-Arino M, Torrente Jimenez I, Cartanya Gutierrez A, Oliva Morera JC, Comet R. Assessing the strengths and weaknesses of the Clinical Frailty Scale through correlation with a frailty index. Aging Clin Exp Res. 2020 Nov;32(11):2225-2232. doi: 10.1007/s40520-019-01450-w. Epub 2020 Jan 2.
- McCullough DJ, Stabley JN, Siemann DW, Behnke BJ. Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise. J Natl Cancer Inst. 2014 Apr;106(4):dju036. doi: 10.1093/jnci/dju036. Epub 2014 Mar 13.
- Macmillan (2023) Physical Activity and Cancer
- Lumivero (2017) NVivo (Version 12).
- Ligibel JA, Bohlke K, Alfano CM. Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline Summary and Q&A. JCO Oncol Pract. 2022 Oct;18(10):695-697. doi: 10.1200/OP.22.00277. Epub 2022 Jul 5. No abstract available.
- Liu Y, Wu W, Cai C, Zhang H, Shen H, Han Y. Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Ther. 2023 Apr 12;8(1):160. doi: 10.1038/s41392-023-01419-2.
- Koller M, Musoro JZ, Tomaszewski K, Coens C, King MT, Sprangers MAG, Groenvold M, Cocks K, Velikova G, Flechtner HH, Bottomley A. Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trials. Lung Cancer. 2022 May;167:65-72. doi: 10.1016/j.lungcan.2022.03.018. Epub 2022 Mar 29.
- Kirkham AA, Campbell KL, McKenzie DC. Comparison of aerobic exercise intensity prescription methods in breast cancer. Med Sci Sports Exerc. 2013 Aug;45(8):1443-50. doi: 10.1249/MSS.0b013e3182895195.
- Kilari D, Soto-Perez-de-Celis E, Mohile SG, Alibhai SM, Presley CJ, Wildes TM, Klepin HD, Demark-Wahnefried W, Jatoi A, Harrison R, Won E, Mustian KM. Designing exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 Meeting. J Geriatr Oncol. 2016 Jul;7(4):293-304. doi: 10.1016/j.jgo.2016.04.007. Epub 2016 May 31.
- Kallio H, Pietila AM, Johnson M, Kangasniemi M. Systematic methodological review: developing a framework for a qualitative semi-structured interview guide. J Adv Nurs. 2016 Dec;72(12):2954-2965. doi: 10.1111/jan.13031. Epub 2016 Jun 23.
- Huffman MK, Christ SL, Ferraro KF, Klenosky DB, Marceau K, Amireault S. Questions to Measure Enjoyment of and Satisfaction With Physical Activity: Are They Appropriate for Use in an Older Population? Innov Aging. 2021 Oct 4;5(4):igab041. doi: 10.1093/geroni/igab041. eCollection 2021.
- Hircock C, Wang AJ, Goonaratne E, Sferrazza D, Bottomley A, Cella D, Lee SF, Chan AW, Chow E, Wong HCY. Comparing the EORTC QLQ-LC13, EORTC QLQ-LC29, and the FACT-L for assessment of quality of life in patients with lung cancer - an updated systematic review. Curr Opin Support Palliat Care. 2024 Dec 1;18(4):260-268. doi: 10.1097/SPC.0000000000000725. Epub 2024 Oct 30.
- Graham-Wisener L, Dempster M, Sadler A, McCann L, McCorry NK. Validation of the Distress Thermometer in patients with advanced cancer receiving specialist palliative care in a hospice setting. Palliat Med. 2021 Jan;35(1):120-129. doi: 10.1177/0269216320954339. Epub 2020 Sep 11.
- Esteves M, Monteiro MP, Duarte JA. The Effects of Physical Exercise on Tumor Vasculature: Systematic Review and Meta-analysis. Int J Sports Med. 2021 Dec;42(14):1237-1249. doi: 10.1055/a-1533-1876. Epub 2021 Aug 2.
- Egegaard T, Rohold J, Lillelund C, Persson G, Quist M. Pre-radiotherapy daily exercise training in non-small cell lung cancer: A feasibility study. Rep Pract Oncol Radiother. 2019 Jul-Aug;24(4):375-382. doi: 10.1016/j.rpor.2019.06.003. Epub 2019 Jun 21.
- Dufresne S, Gueritat J, Chiavassa S, Noblet C, Assi M, Rioux-Leclercq N, Rannou-Bekono F, Lefeuvre-Orfila L, Paris F, Rebillard A. Exercise training improves radiotherapy efficiency in a murine model of prostate cancer. FASEB J. 2020 Apr;34(4):4984-4996. doi: 10.1096/fj.201901728R. Epub 2020 Feb 11.
- Coletta AM, Basen-Engquist KM, Schmitz KH. Exercise Across the Cancer Care Continuum: Why It Matters, How to Implement It, and Motivating Patients to Move. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-7. doi: 10.1200/EDBK_349635.
- Cleland BT, Ingraham BA, Pitluck MC, Woo D, Ng AV. Reliability and Validity of Ratings of Perceived Exertion in Persons With Multiple Sclerosis. Arch Phys Med Rehabil. 2016 Jun;97(6):974-82. doi: 10.1016/j.apmr.2016.01.013. Epub 2016 Feb 1.
- Brown M, Rebillard A, Hart NH, O'Connor D, Prue G, O'Sullivan JM, Jain S. Modulating Tumour Hypoxia in Prostate Cancer Through Exercise: The Impact of Redox Signalling on Radiosensitivity. Sports Med Open. 2022 Apr 8;8(1):48. doi: 10.1186/s40798-022-00436-9.
- Bradley, P., Merchant, Z., Rowlinson-Groves, K., Grundy, S., Al-Najjar, H., Brown, L., Dand, A., Farran, C., Bayman, N., Banfill, K., Wray, D., Moore, J. & Evison, M. (2021) 'P212 Prehab4Cancer: an innovative regional lung cancer prehabilitation service', Thorax, 76 (1), pp. A204-A205
- Beale, L., Carter, H., Doust, J., Brickley, G., Silberbauer, J. & Llyod, G. (2010) 'Exercise heart rate guidelines overestimate recommended intensity for chronic heart failure patients', British Journal of Cardiology, 17, pp.133-137.
- Barker HE, Paget JT, Khan AA, Harrington KJ. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015 Jul;15(7):409-25. doi: 10.1038/nrc3958.
- Balachandran AT, Vigotsky AD, Quiles N, Mokkink LB, Belio MA, Glenn JM. Validity, reliability, and measurement error of a sit-to-stand power test in older adults: A pre-registered study. Exp Gerontol. 2021 Mar;145:111202. doi: 10.1016/j.exger.2020.111202. Epub 2020 Dec 19.
- Atun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B, Hanna TP, Knaul FM, Lievens Y, Lui TY, Milosevic M, O'Sullivan B, Rodin DL, Rosenblatt E, Van Dyk J, Yap ML, Zubizarreta E, Gospodarowicz M. Expanding global access to radiotherapy. Lancet Oncol. 2015 Sep;16(10):1153-86. doi: 10.1016/S1470-2045(15)00222-3.
- Association of Chartered Physiotherapists in Cardiovascular Rehabilitation (2023) Standards for Physical Activity and Exercise in the Cardiovascular Population: 4th Edition
- Vinod SK, Hau E. Radiotherapy treatment for lung cancer: Current status and future directions. Respirology. 2020 Nov;25 Suppl 2:61-71. doi: 10.1111/resp.13870. Epub 2020 Jun 9.
- Varkey B. Principles of Clinical Ethics and Their Application to Practice. Med Princ Pract. 2021;30(1):17-28. doi: 10.1159/000509119. Epub 2020 Jun 4.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 350051
- 25017GP-SS (其他标识符:Belfast Health and Social Care Trust reference)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.